Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia

Placenta

Volumn 36, Issue 9, 2015, Pages 996-1001

  Salvianti, Francesca ^a   Inversetti, Annalisa ^b   Smid, Maddalena ^b   Valsecchi, Luca ^b   Candiani, Massimo ^b   Pazzagli, Mario ^a   Cremonesi, Laura ^b   Ferrari, Maurizio ^b,c   Pinzani, Pamela ^a   Galbiati, Silvia ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Biomarker; Maternal plasma; Preeclampsia; RASSF1A cell free DNA

Indexed keywords

BIOLOGICAL MARKER; FETAL CELL FREE DNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; UNCLASSIFIED DRUG; DNA; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GESTATIONAL AGE; HUMAN; LONGITUDINAL STUDY; MATERNAL AGE; MATERNAL PLASMA; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RISK FACTOR; BLOOD; CHEMISTRY; DNA METHYLATION; EPIDEMIOLOGY; GENETICS; PREDICTIVE VALUE; PREGNANCY;

ADULT; BIOMARKERS; DNA; DNA METHYLATION; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84940205745     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2015.07.003     Document Type: Article

References (24)

1. World Health Organization The World Health Report: 2005: Make Every Mother and Child Count 2005 WHO Geneve
2. Hypertension in pregnancy Report of the American College of obstetricians and gynecologists' task force on hypertension in pregnancy Obstet. Gynecol. 122 2013 1122 1131
3. P. von Dadelszen, L.A. Magee, and J.M. Roberts Subclassification of preeclampsia Hypertens. Pregnancy 22 2003 143 148
4. J.S. Cnossen, G. ter Riet, B.W. Mol, J.A. van der Post, M.M. Leeflang, C.A. Meads, and et al. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal Acta Obstet. Gynecol. Scand. 88 7 2009 758
5. A. Martin, I. Krishna, B. Martina, and A. Samuel Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review Prenat. Diagn. 34 2014 685 691
6. N. Ishihara, H. Matsuo, and H. Murakoshi Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation Am. J. Obstet. Gynecol. 186 2002 158 166
7. T.N. Chan Leung, J. Zhang, T.K. Lau, L.Y. Chan, and Y.M. Lo Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia Clin. Chem. 47 2001 137 139
8. M. Smid, A. Vassallo, F. Lagona, L. Valsecchi, L. Maniscalco, L. Danti, and et al. Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities Ann. N. Y. Acad. Sci. 945 2001 132 137
9. M. Smid, S. Galbiati, A. Lojacono, L. Valsecchi, C. Platto, P. Cavoretto, and et al. Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies Prenat. Diagn. 26 2006 785 790
10. S. Illanes, M. Parra, R. Serra, K. Pino, H. Figueroa-Diesel, C. Romero, and et al. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction Prenat. Diagn. 29 2009 1118 1122
11. S. Galbiati, V. Causarano, P. Pinzani, S. Francesca, C. Orlando, M. Smid, and et al. Evaluation of a panel of circulating DNA, RNA and protein potential markers of pregnancy pathologies Clin. Chem. Lab. Med. 48 2010 791 794
12. D.W. Tsui, K.C. Chan, S.S. Chim, L.W. Chan, T.Y. Leung, T.K. Lau, and et al. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia Prenat. Diagn. 27 2007 1212 1218
13. I. Hromadnikova, L. Zejskova, K. Kotlabova, T. Jancuskova, J. Doucha, K. Dlouha, and et al. Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences-evaluation of diagnostic possibilities for predicting placental insufficiency DNA Cell Biol. 29 2010 295 301
14. N. Papantoniou, V. Bagiokos, K. Agiannitopoulos, A. Kolialexi, A. Destouni, G. Tounta, and et al. RASSF1A in maternal plasma as a molecular marker of preeclampsia Prenat. Diagn. 33 2013 682 687
15. M.J. Kim, S.Y. Kim, S.Y. Park, H.K. Ahn, J.H. Chung, and H.M. Ryu Association of fetal derived hypermethilated RASSF1A concentration in placenta-mediated pregnancy complications Placenta 34 2013 57 61
16. D.L. Rolnik, N. O'Gorman, M. Fiolna, D. van den Boom, K.H. Nicolaides, and L.C. Poon Maternal plasma cell-free DNA in the prediction of pre-eclampsia Ultrasound Obstet. Gunecol. 45 2015 106 111
17. K.C. Chan, C. Ding, A. Gerovassili, S.W. Yeung, R.W. Chiu, T.N. Leung, and et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis Clin. Chem. 52 2006 2211 2218
18. B.S. Everitt The Cambridge Dictionary of Statistics second ed. 2002 Cambridge University Press
19. W.J. Youden Index for rating diagnostic tests Cancer 3 1950 32 35
20. J.T. Henderson, E.P. Whitlock, E. O'Connor, C.A. Senger, J.H. Thompson, and M.G. Rowland Low dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. preventive services task force Ann. Intern Med. 160 2014 695 703
21. S. Galbiati, A. Inversetti, V. Causarano, S. Stenirri, N. Soriani, A. Ambrosi, L. Valsecchi, M. Candiani, L. Cremonesi, M. Ferrari, and M. Smid HIF1A and MIF as potential predictive mRNA biomarkers of pre-eclampsia: a longitudinal prospective study in high risk population Clin. Chem. Lab. Med. 2014 Dec 2 pii:/j/cclm.ahead-of-print/cclm-2014-0745/cclm-2014-0745.xml. http://dx.doi.org/10.1515/cclm-2014-0745 (Epub ahead of print) PMID: 25460285
22. T.H. Rainer, L.K. Wong, W. Lam, E. Yuen, N.Y. Lam, C. Metreweli, and et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke Clin. Chem. 49 2003 562 569
23. E.A. Steegers, P. von Dadelszen, J.J. Duvekot, and R. Pijnenborg Pre-eclampsia Lancet 376 9741 2010 631 644
24. C.W. Redman, I.L. Sargent, and A.C. Staff IFPA Senior Award Lecture: making sense of pre-eclampsia- two placental causes of preeclampsia? Placenta 35 Suppl. 2014 Feb S20 S25